Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon rupture during use, which may add time to the procedure and compromises the safety of the patient.

Internet search engine giant Google unveiled a new Doodle on its homepage Friday, July 12, celebrating the life and work of cardiac surgeon Rene Favaloro. Favarolo, originally from Argentina, was one of the early pioneers of coronary artery bypass graft (CABG) surgery.

Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will present at the 14th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT), July 11-14 in Baltimore. His session is titled “Building a National Centers of Excellence in Coronary Computed Tomography Angiography (CCTA) to Support Implementation in Clinical Practice.”

The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational Device Exemption (IDE) Clinical Trials.”

W. L. Gore & Associates Inc. (Gore) announced the first U.S. implant of the Gore Tag Conformable Thoracic Stent Graft with Active Control System. The successful procedure was performed by William Jordan, M.D., chief of the Division of Vascular Surgery and Bradley Leshnower, M.D., cardiothoracic surgeon, at the Emory University School of Medicine in Atlanta. This first case follows the recent U.S. Food and Drug Administration (FDA) approval for this new device.

Neovasc Inc. announced that its Tiara transcatheter mitral valve replacement (TMVR) device and its Neovasc Reducer device for the treatment of refractory angina were highlighted in presentations at the CSI Frankfurt 2019 conference, June 26-29, in Frankfurt, Germany.